Skip to main content

Table 4 The discovered missense mutations into the coding sequence of CLDN5 gene

From: The CLDN5 gene at the blood-brain barrier in health and disease

Mutant

Number

Note

Ref

G60R (c.178G > A)

4

All of them developed hemiplegia and 2 of them are diagnosed with AHC.

[159, 160]

G60R (c.178G > C)

1

Not developed hemiplegia so far.

[160]

V41M (c.121G > A)

3

Its barrier forming ability was normal in epithelial cells overexpressing this mutant.

[160] [151]

Q63K (c.187 C > A)

1

The most severe phenotype was observed.

[160]

N39S (c.116 A > G)

2

It is located in the interface of trans-interaction

[160]

F35L (c.105 C > G)

1

It is located in the interface of trans-interaction

[160]

I40V (c.118 A > G)

1

It is located in the interface of trans-interaction

[160]

A43P (c.127G > C)

1

It is located in the interface of trans-interaction

[160]

V55A (c.164T > C)

1

It is located in the gate region

[160]

S58R (c.174 C > G)

1

It is located in the gate region

[160]

  1. All patients develop epilepsy, calcium deposition in the basal ganglia and microcephaly